What Does Diabeloop Do?

Total employees95
HeadquartersGrenoble
Founded2015

Diabeloop is a medical technology company that develops innovative artificial intelligence-based solutions to automate and personalize diabetes management. Their primary focus is on improving the quality of life for people with type 1 diabetes through closed-loop systems that connect continuous glucose monitors (CGMs) and insulin pumps. Diabeloop's CE-marked systems, like DBLG1 and DBL-hu, aim to reduce the daily burden of diabetes by providing automated insulin delivery, thus helping to stabilize blood glucose levels and reduce hypoglycemic and hyperglycemic episodes. The company collaborates closely with patients, healthcare professionals, and research institutions to develop user-centric and clinically effective technologies.

Where Is Diabeloop's Headquarters?

HQ Function

The Grenoble headquarters serves as the central hub for Diabeloop's research and development, strategic planning, global operations, and administrative functions. It's where their core AI algorithms and diabetes management solutions are conceived and refined.

Notable Features:

The headquarters is likely located within a technology-focused business park, featuring modern office spaces, R&D laboratories equipped for medical device development, and collaborative environments designed to foster innovation.

Work Culture:

Diabeloop's HQ likely fosters a highly collaborative, innovative, and patient-centric work culture. Employees are driven by a mission to improve the lives of people with diabetes, with a strong emphasis on scientific rigor, technological advancement, and interdisciplinary teamwork.

HQ Significance:

The Grenoble location is significant due to its proximity to leading research institutions, a skilled talent pool in engineering and medical technology, and a supportive ecosystem for high-tech startups. This environment is crucial for Diabeloop's cutting-edge R&D in therapeutic AI.

Values Reflected in HQ: The headquarters likely reflects Diabeloop's values of innovation, scientific excellence, collaboration, and a commitment to patient well-being, possibly through its design, layout, and the technology utilized within the space.

Location:

Diabeloop is headquartered in Grenoble, France, with key offices in Paris, France, and Menlo Park, California, USA. While core R&D and product development are centered in France, the company has established a commercial presence across several European countries including Germany, the Netherlands, Italy, Spain, and Switzerland. Its expansion into the United States and collaborations in markets like Japan signify its growing global reach. Diabeloop supports functions like clinical research, regulatory affairs, sales, marketing, and customer support internationally to make its AI-driven diabetes solutions accessible to a wider patient population.

Street Address:

17 Rue Félix Esclangon

City:

Grenoble

State/Province:

Auvergne-Rhône-Alpes

Country:

France

Where Else Does Diabeloop Operate Around the World?

Paris, Île-de-France/France

Address: 5 Rue de la Baume, 75008 Paris

Serves as a strategic hub for national and potentially European commercial activities, communication, and networking within the French healthcare ecosystem.

Menlo Park, California/USA

Address: 101 Jefferson Drive, 1st Floor, Menlo Park, CA 94025

Key for accessing the significant US diabetes market, engaging with US-based research institutions, healthcare providers, and navigating the American regulatory landscape.

Buying Intent Signals for Diabeloop

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Diabeloop? Meet the Executive Team

As of April 2025, Diabeloop' leadership includes:

Marc Julien - Co-CEO
Erik Huneker - Founder & Member of the Board
Catherine Jullien-Breches - Chief Financial Officer
Cécile Ferracci - Chief Business Officer & General Manager Europe
Stéphane Majerus - Chief R&D and Technology Officer
Sophie Taraccessible - Chief Quality & Regulatory Officer

Who's Investing in Diabeloop?

Diabeloop has been backed by several prominent investors over the years, including:

LBO France
Terumo Corporation
Bpifrance
Innovacom
UI Investissement (Sofimac Innovation)
CERITD
AdP (Airports de Paris Group)
Kreos Capital
AGIR à dom
CEMAG Invest
Odyssée Venture

What Leadership Changes Has Diabeloop Seen Recently?

Hire2
Exits0

Diabeloop has strategically reinforced its leadership over the past year, notably by appointing a new Chief Financial Officer and a Head of Legal & Compliance. These key hires are aimed at supporting the company's ongoing growth, international expansion, and navigation of complex regulatory landscapes in the medical technology sector.

New Appointments:

Catherine Jullien-Breches, Catherine Jullien-Breches appointed as Chief Financial Officer to steer financial strategy and operations.
Joseph Dumas, Joseph Dumas joined as Head of Legal & Compliance to oversee legal frameworks and adherence to regulations.

What Technology (Tech Stack) Is Used byDiabeloop?

Discover the tools Diabeloop uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Diabeloop Email Formats and Examples

Diabeloop primarily uses the `first.last@diabeloop.com` email format for its employees. This is a common structure for professional communication within technology and healthcare companies and has been observed in public communications from the company.

first.last@diabeloop.com

Format

jane.doe@diabeloop.com

Example

90%

Success rate

What's the Latest News About Diabeloop?

Diabeloop Official WebsiteApril 24, 2024

Diabeloop’s DBLG1 System Shows Major Glycemic Improvements in Real-World T1D Study

A real-world study of Diabeloop's DBLG1 system demonstrated significant and sustained improvements in glycemic control for individuals with Type 1 diabetes, highlighting its effectiveness in everyday life....more

Diabeloop Official WebsiteFebruary 27, 2024

Diabeloop and Terumo Expand Partnership for AID Solution with Patch Pump in Japan

Diabeloop and Terumo Corporation are strengthening their collaboration to expedite the launch of an automated insulin delivery (AID) system featuring a patch pump in Japan, aiming to enhance diabetes care in the region....more

Diabeloop Official WebsiteDecember 5, 2023

Diabeloop Obtains FDA Clearance for DBL-Easy Software for Smart Pen Solution in U.S.

Diabeloop announced it has received clearance from the U.S. Food and Drug Administration (FDA) for DBL-Easy, its software application designed to be used with smart insulin pens for people with type 1 or type 2 diabetes....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Diabeloop, are just a search away.